The magnitude and sustainability of treatment benefit of zuranolone on function and well-being as assessed by the SF-36 in adult patients with MDD and PPD: An integrated analysis of 4 randomized clinical trials-Reference-Cited by-同舟云学术

The magnitude and sustainability of treatment benefit of zuranolone on function and well-being as assessed by the SF-36 in adult patients with MDD and PPD: An integrated analysis of 4 randomized clinical trials

Published:2024-04 Issue: Volume:351 Page:904-914
ISSN:0165-0327
Container-title:Journal of Affective Disorders
language:en
Short-container-title:Journal of Affective Disorders

Author:

Clayton Anita H.,Suthoff Ellison,Jain Rakesh,Kosinski Mark,Fridman Moshe,Deligiannidis Kristina M.,Meltzer-Brody Samantha,Chen Shih-Yin,Gervitz Leon,Huang Ming-Yi,Trivedi Madhukar,Bonthapally Vijayveer

Publisher

Elsevier BV

Reference67 articles.

1. ACOG Committee Opinion No. 757: Screening for Perinatal Depression;ACOG,2018

2. Antidepressants and health-related quality of life (HRQoL) for patients with depression: analysis of the medical expenditure panel survey from the United States;Almohammed;PLoS One,2022

3. Preclinical characterization of zuranolone (SAGE-217), a selective neuroactive steroid GABA(a) receptor positive allosteric modulator;Althaus;Neuropharmacology,2020

4. Diagnostic and Statistical Manual of Mental Disorders (DSM-5);American Psychiatric Association,2013

5. Depression and quality of life: results of a follow-up study;Angermeyer;Int. J. Soc. Psychiatry,2002

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Novel insight into astrocyte-mediated gliotransmission modulates the synaptic plasticity in major depressive disorder;Life Sciences;2024-10

2. Expanding the therapeutic potential of neuro(active)steroids: a promising strategy for hyperdopaminergic behavioral phenotypes;Neuroscience & Biobehavioral Reviews;2024-09

3. Sex Differences in Alcohol Use: Is It All About Hormones?;Endocrinology;2024-07-17